Ryuichi Hasegawa

9.3k citations
147 papers · 4.4k indexed · h-index 42

Ryuichi Hasegawa

143 papers receiving 4.3k citations

Peers

Ryuichi Hasegawa
Comparison fields: 5 of 160
  • Pharmacology 746
  • Pharmacology 749
  • Health, Toxicology and Mutagenesis 524
  • Cancer Research 521
  • Oncology 840
Replace Glenda C. Gobé with:
Glenda C. Gobé Australia
Ying‐Yong Zhao China
Sudhir V. Shah United States
John A. Timbrell United Kingdom
Yeong‐Shiau Pu Taiwan
Stamatios Theocharis Greece
Sang Kyum Kim South Korea
Marc E. De Broe Belgium
Toshimitsu Niwa Japan
Frans G. M. Rüssel Netherlands
Ryuichi Hasegawa relative to Glenda C. Gobé Australia Glenda C. Gobé's profile →
Citations per field
00.5×1.6×
Glenda C. Gobé · 1×
Citations per year

Countries citing papers authored by Ryuichi Hasegawa

Since Specialization
Citations

This map shows the geographic impact of Ryuichi Hasegawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryuichi Hasegawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryuichi Hasegawa more than expected).

Fields of papers citing papers by Ryuichi Hasegawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryuichi Hasegawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryuichi Hasegawa. The network helps show where Ryuichi Hasegawa may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ryuichi Hasegawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ryuichi Hasegawa Line = papers co-authored together Ryuichi Hasegawa links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20238
2 201523
3 20121
4
20101
5 200820
6 200850
7 20072
8 200711
9
[Study on environmental risk assessment of drugs: excretion forms to environment].
20061
10
[Improvement of package insert CYP information for prescription drugs marketed in Japan].
20054
11 200531
12 200485
13 20023
14
O12-11 Comparative study on toxicological profile and no observed adverse effect level of 2, 4-initrophenol in newborn and young rats
20012
15 20011
16 19991
17
Classification of herbaceous peony [Paeonia lactiflora] cultivars by random amplified polymorphic DNA (RAPD) analysis
19973
18 199556
19 199063
20
Effects of wu-ling-san on alcohol metabolism and alcoholic liver.
19854

About Ryuichi Hasegawa

Ryuichi Hasegawa is a scholar working on Pharmacology, Health, Toxicology and Mutagenesis and Cancer Research, having authored 147 papers that have together received 4.4k indexed citations. Recurring topics across this work include Effects and risks of endocrine disrupting chemicals (23 papers), Drug Transport and Resistance Mechanisms (21 papers), Pharmacogenetics and Drug Metabolism (20 papers), Carcinogens and Genotoxicity Assessment (18 papers), Toxic Organic Pollutants Impact (14 papers), Respiratory Support and Mechanisms (7 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Drug-Induced Adverse Reactions (6 papers). The work is most often cited by research in Pharmacology (746 citations), Pharmacology (749 citations) and Health, Toxicology and Mutagenesis (524 citations). Ryuichi Hasegawa has collaborated with scholars based in Japan, United States and Sri Lanka. Frequent co-authors include Yuji Kurokawa, Kimie Sai, Takashi Umemura, Atsuya Takagi, Yoshiro Saito, Masahiro Tohkin, Masao Doi, Nahoko Kaniwa, Jun‐ichi Sawada and Kouichi Kurose. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026